Literature DB >> 12399360

Risk: benefit ratio is important in treating atopic dermatitis.

B Roger Allen, Thomas A Luger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12399360      PMCID： PMC1124459          DOI： 10.1136/bmj.325.7370.970

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Toll of allergy reduced by probiotics.

Authors:  S H Murch
Journal:  Lancet       Date:  2001-04-07       Impact factor: 79.321

2.  New treatments for atopic dermatitis.

Authors:  Hywel Williams
Journal:  BMJ       Date:  2002-06-29

3.  Topical corticosteroid phobia in patients with atopic eczema.

Authors:  C R Charman; A D Morris; H C Williams
Journal:  Br J Dermatol       Date:  2000-05       Impact factor: 9.302

4.  Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children.

Authors:  S Kang; A W Lucky; D Pariser; I Lawrence; J M Hanifin
Journal:  J Am Acad Dermatol       Date:  2001-01       Impact factor: 11.527

5.  Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.

Authors:  Ulrich Wahn; Jan D Bos; Mark Goodfield; Ruggero Caputo; Kim Papp; Ahmed Manjra; Attila Dobozy; Carle Paul; Stephen Molloy; Thomas Hultsch; Michael Graeber; Robert Cherill; Yves de Prost
Journal:  Pediatrics       Date:  2002-07       Impact factor: 7.124
  5 in total
  1 in total

1.  Risk-benefit analysis: from a logical point of view.

Authors:  Georg Spielthenner
Journal:  J Bioeth Inq       Date:  2012-03-21       Impact factor: 1.352
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.